Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence.
about
Modeling Influenza Virus Infection: A Roadmap for Influenza ResearchReversing T cell immunosenescence: why, who, and howAntigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.Towards a comprehensive public health response to population ageing.Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection.Influenza-associated hospitalizations, Singapore, 2004-2008 and 2010-2012.Socioeconomic status and other related factors of seasonal influenza vaccination in the South Korean adult population based on a nationwide cross-sectional study.The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.Predictors of influenza among older adults in the emergency department.Influenza vaccines and vaccinations in Poland - past, present and future.B cell responses to the 2011/12-influenza vaccine in the aged.The temporal trend of influenza-associated morbidity and the impact of early appearance of antigenic drifted strains in a Southeast Asian country.Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay.The influence of ageing on the development and management of rheumatoid arthritis.Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.Vaccination in the elderly: what can be recommended?Markers of T Cell Senescence in Humans.Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain.Roads to advanced vaccines: influenza case study.Inflammatory responses to influenza vaccination at the extremes of age.Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1.Vaccine approaches conferring cross-protection against influenza viruses.A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.Influenzanet: Citizens Among 10 Countries Collaborating to Monitor Influenza in EuropeThe effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15.Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering.Vaccination choices for older people, looking beyond age specific approaches.When climate change encounters the revolution in adult longevity.Interventions to restore appropriate immune function in the elderly.Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity.Challenges in adult vaccination.The Association between Smoking Status and Influenza Vaccination Coverage Rate in Korean Adults: Analysis of the 2010-2012 Korea National Health and Nutrition Examination Survey.
P2860
Q26782421-577587CE-7511-47DB-8303-201BC7206199Q27003902-ABE0D0A2-EDC4-4829-84E6-73826807CC79Q30360768-0E0F39EE-5CC9-4833-BE45-479BA3902954Q30683841-3E545986-B6F0-4380-B054-05FB6D621824Q31155532-0042A7BA-F700-411B-8436-51FB8F3DE859Q34320911-4E4C5AC3-0921-436F-B95B-666B3FA903C7Q35043989-BA0146CC-C08E-483C-BB76-A7E38B918724Q35225020-5FFD45D0-BB00-4347-8EF3-1B6C4D3E09F9Q36177516-68A2097D-7D5A-461C-A0CD-C994D557BED8Q36576966-7121653E-230A-4C6C-8723-F700DFD2B93FQ36774876-383A7ECD-9D51-41F3-8DEF-ACD6FA8A1E25Q37452677-BC1881B8-A735-49E2-9CC6-F0EAC12CED20Q37629980-34C087A5-86E2-4D82-8FDD-9BB79329AF62Q38115131-B0552598-509E-433A-ABFE-8526E9942AA1Q38204774-E516256F-F431-435D-A700-0549F3C47215Q38220158-4569B5F5-3A5B-488C-81C6-0E27CDDA6B4FQ38644422-522BDA28-8C15-4935-85D2-A81300018500Q38715669-7543B7A8-C6DD-498A-81D6-32FF087BE005Q40092863-41E13D5D-43B1-481C-B0C4-F64C615E9462Q40259120-105D14C6-D0E9-4C61-AE50-34E271E515A2Q40822873-5589F373-AA4F-465D-A645-11A84667A455Q41934895-D57F2DFF-4A56-412D-9197-DAD937063635Q41935331-016DA5EC-9E0B-465F-B052-EDE5E20ABE11Q41996360-3CABCBFF-EE7E-4D52-B3F1-7E02B0C92407Q47136504-E1A0542A-DA67-43CD-9B12-94CE47F06D14Q47563152-2C8CAE4E-B883-4C0C-A561-BFED66731790Q47595817-E07952C2-08DF-4179-B3E1-58991E0E723EQ48117731-C8C3165C-E33D-42EE-A451-767B39CBD779Q49186484-F534AC68-C822-4B36-A742-60963C81B09FQ51767342-38C33F9C-A330-4790-B41F-F14068349AB8Q51773551-6869CB09-254D-4D8C-B8FD-57DA5C782C2FQ53075018-F1400827-5CAB-442E-97AD-123EBABBA2CB
P2860
Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effectiveness of influenza vac ...... sive analysis of the evidence.
@ast
Effectiveness of influenza vac ...... sive analysis of the evidence.
@en
type
label
Effectiveness of influenza vac ...... sive analysis of the evidence.
@ast
Effectiveness of influenza vac ...... sive analysis of the evidence.
@en
prefLabel
Effectiveness of influenza vac ...... sive analysis of the evidence.
@ast
Effectiveness of influenza vac ...... sive analysis of the evidence.
@en
P2093
P2860
P356
P1476
Effectiveness of influenza vac ...... sive analysis of the evidence.
@en
P2093
Aline Mendes
Jennifer Socquet
Noémie Assir
Pierre-Olivier Lang
Richard Aspinall
Sheila Govind
P2860
P356
10.2147/CIA.S25215
P407
P577
2012-02-24T00:00:00Z